First National Bank of South Miami’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-144
Closed -$9K 321
2022
Q1
$9K Hold
144
0.01% 290
2021
Q4
$10K Hold
144
0.01% 302
2021
Q3
$9K Hold
144
0.01% 285
2021
Q2
$9K Hold
144
0.01% 280
2021
Q1
$9K Buy
+144
New +$8.69K 0.01% 267

Other funds holding IHE

First National Bank of South Miami's IHE Position: Q2 2022 in Review

First National Bank of South Miami sold out of iShares US Pharmaceuticals ETF (IHE) in Q2 2022, closing a stake of 144 shares — an estimated $9K sold.

First National Bank of South Miami first reported a position in IHE in Q1 2021 and held it in 5 quarters. The position peaked at $10K in Q4 2021. 125 funds tracked by Wall St. Rank hold IHE as of Q2 2022.

  • First National Bank of South Miami reported no remaining iShares US Pharmaceuticals ETF position as of Q2 2022 after selling out during the quarter.
  • First National Bank of South Miami sold 144 iShares US Pharmaceuticals ETF shares in Q2 2022, an estimated $9K.
  • First National Bank of South Miami first reported a position in iShares US Pharmaceuticals ETF in Q1 2021 and held it in 5 quarters.
  • First National Bank of South Miami's iShares US Pharmaceuticals ETF position peaked at $10K in Q4 2021.
  • 125 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2022.

Based on First National Bank of South Miami's 13F filing for Q2 2022, filed 13 Jul 2022.